Berkeley Lights IPO Presentation Deck

BI 6 Antibody Therapeutics Aim to become the Preferred Path from Target ID to the Clinic Based on internal and external estimates in 2019 ~$6B1 TAM -$222B END MARKET IN 2024 23

View entire presentation